Document is current
Any future updates will be listed below
-
Authors
Jackson, Sarah E.
Oldham, Melissa
Garnett, Claire
Brown, Jamie
Shahab, Lion
Cox, Sharon
-
Funding
Funding for this research was provided by:
Cancer Research UK (PRCRPG-Nov21\100002, PRCRPG-Nov21\100002, PRCRPG-Nov21\100002, PRCRPG-Nov21\100002)
- License Information
-
More Information
Article History
Received: 18 March 2024
Accepted: 7 February 2025
First Online: 26 February 2025
Declarations
:
: JB has received unrestricted research funding from Pfizer and J&J, who manufacture smoking cessation medications. LS has received honoraria for talks, unrestricted research grants and travel expenses to attend meetings and workshops from manufactures of smoking cessation medications (Pfizer; J&J), and has acted as paid reviewer for grant awarding bodies and as a paid consultant for health care companies. All authors declare no financial links with tobacco or alcohol companies, e-cigarette manufacturers, or their representatives.
: Ethical approval for the Smoking Toolkit Study was granted originally by the UCL Ethics Committee (ID 0498/001). All methods were performed in accordance with the relevant guidelines and regulations. Informed consent was obtained from all participants. The data were collected by IPSOS MORI and were anonymised when received by UCL.
